Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 2
1969 1
1970 2
1973 1
1975 1
1993 1
2009 1
2010 2
2011 1
2012 2
2013 1
2014 3
2015 3
2016 1
2017 1
2018 2
2019 4
2020 7
2021 6
2022 11
2023 3
2024 7
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: misch m. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Free article. Clinical Trial.
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, Hübschmann D, Toprak UH, López C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Pehl D, Radbruch H, Osterloh A, Korfel A, Misch M, Onken J, Faust K, Vajkoczy P, Moskopp D, Wang Y, Jödicke A, Trümper L, Anagnostopoulos I, Lenze D, Küppers R, Hummel M, Schmitt CA, Wiestler OD, Wolf S, Unterberg A, Eils R, Herold-Mende C, Brors B; ICGC MMML-Seq Consortium; Siebert R, Wiemann S, Heppner FL. Radke J, et al. Among authors: misch m. Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y. Nat Commun. 2022. PMID: 35538064 Free PMC article.
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP, Bendszus M, von Deimling A, Schmitt M, Wick W. Platten M, et al. Among authors: misch m. Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24. Nature. 2021. PMID: 33762734 Free PMC article. Clinical Trial.
Robust methylation-based classification of brain tumours using nanopore sequencing.
Kuschel LP, Hench J, Frank S, Hench IB, Girard E, Blanluet M, Masliah-Planchon J, Misch M, Onken J, Czabanka M, Yuan D, Lukassen S, Karau P, Ishaque N, Hain EG, Heppner F, Idbaih A, Behr N, Harms C, Capper D, Euskirchen P. Kuschel LP, et al. Among authors: misch m. Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12856. doi: 10.1111/nan.12856. Epub 2022 Nov 9. Neuropathol Appl Neurobiol. 2023. PMID: 36269599
Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection.
Wasilewski D, Araceli T, Rafaelian A, Demetz M, Asey B, Ersoy TF, Dauth A, Neumeister A, Peukert R, Pöser P, Krämer C, Bukatz J, Shaked Z, Jelgersma C, Früh A, Xu R, Misch M, Capper D, Ehret F, Frost N, Bullinger L, Keilholz U, Senft C, Schmidt L, Krenzlin H, Ringel F, Pohrt A, Meyer HS, Gempt J, Kerschbaumer J, Freyschlag C, Thomé C, Simon M, Dubinski D, Freiman T, Schmidt NO, Proescholdt M, Vajkoczy P, Onken J. Wasilewski D, et al. Among authors: misch m. JAMA Netw Open. 2025 Apr 1;8(4):e254689. doi: 10.1001/jamanetworkopen.2025.4689. JAMA Netw Open. 2025. PMID: 40214989 Free PMC article.
Sports Medicine Update: Concussion.
Misch MR, Raukar NP. Misch MR, et al. Emerg Med Clin North Am. 2020 Feb;38(1):207-222. doi: 10.1016/j.emc.2019.09.010. Emerg Med Clin North Am. 2020. PMID: 31757251 Review.
Managing hydrocephalus in patients with leptomeningeal disease: A multicenter retrospective analysis.
Alhalabi OT, Klein L, Wasilewski D, Mellal A, Büsken C, Buszello C, Cossu G, Eyüpoglu IY, Unterberg AW, Vajkoczy P, Schackert G, Messerer M, Misch M, Kessler T, Wick W, Jungk C, El Damaty A, Krieg SM, Juratli TA, Younsi A. Alhalabi OT, et al. Among authors: misch m. Int J Cancer. 2025 Oct 15;157(8):1613-1624. doi: 10.1002/ijc.35505. Epub 2025 Jun 4. Int J Cancer. 2025. PMID: 40464488 Free PMC article.
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.
Keric N, Krenzlin H, Kalasauskas D, Freyschlag CF, Schnell O, Misch M, von der Brelie C, Gempt J, Krigers A, Wagner A, Lange F, Mielke D, Sommer C, Brockmann MA, Meyer B, Rohde V, Vajkoczy P, Beck J, Thomé C, Ringel F. Keric N, et al. Among authors: misch m. J Neurooncol. 2024 Mar;167(1):133-144. doi: 10.1007/s11060-024-04585-7. Epub 2024 Feb 7. J Neurooncol. 2024. PMID: 38326661 Free PMC article.
66 results